Robert Gatenby Selected Research

Robert Gatenby Research Topics

18	Neoplasms (Cancer) 01/2024 - 10/2005
4	Prostatic Neoplasms (Prostate Cancer) 01/2024 - 01/2020
2	Breast Neoplasms (Breast Cancer) 01/2024 - 09/2023
2	Glioblastoma (Glioblastoma Multiforme) 01/2022 - 01/2007
2	Multiple Myeloma 04/2020 - 01/2017
1	Ovarian Neoplasms (Ovarian Cancer) 03/2023
1	Neoplasm Metastasis (Metastasis) 01/2023
1	Bites and Stings (Sting) 01/2023
1	Esophageal Neoplasms (Esophageal Cancer) 01/2023
1	Edema (Dropsy) 02/2014
1	Hypoxia (Hypoxemia) 02/2006

2	AndrogensIBA 01/2024 - 01/2023
2	Capecitabine (Xeloda)FDA Link 01/2024 - 09/2023
2	Gemcitabine FDA Link 01/2024 - 09/2023
2	Biomarkers (Surrogate Marker)IBA 01/2023 - 02/2014
2	Oxygen (Dioxygen)IBA 02/2006 - 10/2005
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 03/2023
1	InflammasomesIBA 01/2023
1	Prostate-Specific Antigen (Semenogelase)IBA 01/2023
1	Tyrosine Kinase InhibitorsIBA 01/2023
1	Interferon Type IIBA 01/2023
1	Methionine (L-Methionine)FDA Link 01/2023
1	SolutionsIBA 01/2022
1	Abiraterone AcetateIBA 01/2022
1	abirateroneIBA 01/2022
1	N-acetyltalosaminuronic acid (NAT)IBA 10/2018
1	venetoclaxIBA 01/2017
1	ricolinostatIBA 01/2017
1	Adenosine Triphosphate (ATP)IBA 01/2015
1	GadoliniumIBA 02/2014
1	Tumor Biomarkers (Tumor Markers)IBA 02/2009
1	Proteins (Proteins, Gene)FDA Link 02/2009
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 02/2006